Fred Alger Management »

Cymabay Therapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Cymabay Therapeutics shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Cymabay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cymabay Therapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cymabay Therapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $47M 2.0M 23.62
2023-09-30 $32M 2.2M 14.91

More positions owned by Fred Alger Management

Microsoft Corp Common (MSFT)
Nvidia Corp. Common (NVDA)
Amazon Common (AMZN)
Meta Platforms Inc Class A Common (META)
Apple Common (AAPL)
Natera Common (NTRA)
Alphabet Inc Cl C Common (GOOG)
Visa Inc Class A Shares Common (V)
Netflix Common (NFLX)
Advanced Micro Devices Common (AMD)
Broadcom Common (AVGO)
Taiwan Semiconductor Common (TSM)
Transdigm Group Common (TDG)
Eli Lilly & Co Common (LLY)
Vertiv Holdings Common (VRT)

View all positions for Fred Alger Management

Top funds holding Cymabay Therapeutics

venBio Select Advisor
Nicholas Investments Partners
Alliancebernstein
Wellington Management Company
Algert Coldiron Investors
ALPS Advisors
MetLife Investment Advisors
American International
Golden State Equity Partners
Healthcare Of Ontario Pension Plan Trust Fund
Metropolitan Life Insurance Company
Tucker Asset Management
EverSource Wealth Advisors
IFP Advisors
Able Wealth Management

View all funds holding Cymabay Therapeutics